Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

Gates Medical Research Institute

Tracked across 3 events · 28 articles · First seen Jul 02, 2026 · Last active Aug 17, 2026

Sentiment
43
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Sponsor of Phase 3 trial and technology transfer partner; key driver of vaccine development.
Jul 16, 2026 · 14 articles
2 30
Tech
Altor BioScience submitted a Clinical Trial Application to the South Africa — South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive…
Impact: Gates MRI licensed RSM01 to Altor BioScience and conducted early research and Phase 1a. The trial advances a candidate from its portfolio, potentially validating its research.
Jul 20, 2026 · 7 articles
4 30
Tech
Impact: Gates Medical Research Institute has an agreement with Altor BioScience for the development of an RSV antibody therapy, showcasing ongoing partnerships in medical research.
Jul 02, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Gates Medical Research Institute live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.